FINWIRES · TerminalLIVE
FINWIRES

Travere Therapeutics Insider Sold Shares Worth $1,015,086, According to a Recent SEC Filing

作者

-- Jula Inrig, Chief Medical Officer, on May 04, 2026, sold 22,485 shares in Travere Therapeutics (TVTX) for $1,015,086. Following the Form 4 filing with the SEC, Inrig has control over a total of 113,238 common shares of the company, with 113,238 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1438533/000190236826000006/xslF345X05/form4-05062026_080509.xml

相關文章